Akebia Therapeutics, Inc.
NASDAQ:AKBA
1.35 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 42.925 | 90.466 | 149.8 | 228.698 | 147.449 | 104.644 | 70.156 | 187.335 | 49.778 | 32.78 | 21.215 | 1.641 |
| Short Term Investments
| 0 | 0 | 0 | 39.992 | 0.245 | 216.996 | 247.636 | 73.008 | 88.676 | 76.138 | 11.341 | 0 |
| Cash and Short Term Investments
| 42.925 | 90.466 | 149.8 | 268.69 | 147.694 | 321.64 | 317.792 | 260.343 | 138.454 | 108.918 | 32.556 | 1.641 |
| Net Receivables
| 39.29 | 39.18 | 50.875 | 26.853 | 38.864 | 16.666 | 34.216 | 33.823 | 0 | 0.048 | 0.135 | 0.086 |
| Inventory
| 15.691 | 21.762 | 38.195 | 61.017 | 116.349 | 114.245 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 20.243 | 33.541 | 33.14 | 14.877 | 6.626 | 15.724 | 6.348 | 2.155 | 2.563 | 1.514 | 0.739 | 0.517 |
| Total Current Assets
| 118.149 | 184.949 | 272.01 | 371.437 | 309.533 | 468.275 | 358.356 | 296.321 | 141.017 | 110.48 | 33.431 | 2.244 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 16.045 | 34.372 | 40.606 | 35.498 | 39.418 | 8.023 | 3.617 | 2.612 | 0.54 | 0.21 | 0.03 | 0 |
| Goodwill
| 59.044 | 55.053 | 55.053 | 55.053 | 55.053 | 55.053 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 36.042 | 72.084 | 108.127 | 144.17 | 291.212 | 328.153 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 95.086 | 127.137 | 163.18 | 199.223 | 346.265 | 383.206 | -1.462 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 1.654 | 2.703 | 2.039 | 2.039 | 2.092 | 2.455 | 1.281 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | -2.703 | -2.039 | -2.039 | -2.092 | 112.777 | 0.181 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 10.769 | 5.372 | 49.754 | 37.981 | 75.985 | 21.804 | 2.274 | 1.283 | 1.383 | 0.305 | 1.203 | 0 |
| Total Non-Current Assets
| 123.554 | 166.881 | 253.54 | 272.702 | 461.668 | 528.265 | 5.891 | 3.895 | 1.923 | 0.515 | 1.234 | 0 |
| Total Assets
| 241.703 | 351.83 | 525.55 | 644.139 | 771.201 | 996.54 | 364.247 | 300.216 | 142.94 | 110.995 | 34.665 | 2.244 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 14.635 | 18.021 | 33.588 | 41.308 | 39.217 | 42.796 | 6.998 | 2.039 | 2.313 | 2.021 | 0.714 | 0.418 |
| Short Term Debt
| 24.039 | 36.744 | 102.345 | 5.286 | 4.989 | 15 | 0.987 | 0.009 | 0.008 | 0 | 0.004 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0.987 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 22.94 | 3.738 | 20.906 | 15.214 | 39.83 | 56.98 | 84.91 | 81.968 | -0.008 | 0 | 0 | 0 |
| Other Current Liabilities
| 38.256 | 66.253 | 99.654 | 125.338 | 124.082 | 150.917 | 51.454 | 30.252 | 9.555 | 4.864 | 3.184 | 4.505 |
| Total Current Liabilities
| 99.87 | 124.756 | 256.493 | 187.146 | 208.118 | 265.693 | 144.349 | 114.268 | 11.868 | 6.885 | 3.902 | 4.923 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 71.196 | 63.039 | 33.703 | 120.999 | 103.333 | 3.006 | -0.181 | 0 | 0 | 0 | 0.008 | 0 |
| Deferred Revenue Non-Current
| 43.296 | 43.296 | 21.474 | 25.345 | 33.12 | 55.709 | 97.957 | 115.321 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 8.947 | 0 | 1.82 | 2.42 | 1.65 | 6.631 | 0.181 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 48.978 | 111.397 | 135.604 | 60.611 | 30.223 | 29.573 | 2.61 | 2.507 | 0.074 | 0.032 | 0 | 0 |
| Total Non-Current Liabilities
| 172.417 | 217.732 | 192.601 | 209.375 | 168.326 | 94.919 | 100.567 | 117.828 | 0.074 | 0.032 | 0.008 | 0 |
| Total Liabilities
| 272.287 | 342.488 | 449.094 | 396.521 | 376.444 | 360.612 | 244.916 | 232.096 | 11.942 | 6.917 | 3.91 | 4.923 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 110.995 | 157.827 | 56.909 |
| Common Stock
| 0.002 | 0.002 | 0.001 | 0.001 | 0.001 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings
| -1,608.95 | -1,552.913 | -1,460.351 | -1,177.511 | -794.054 | -514.395 | -374.05 | -297.136 | -161.389 | -100.673 | -63.707 | -59.588 |
| Accumulated Other Comprehensive Income/Loss
| 0.006 | 0.006 | 0.006 | 0.013 | 0 | -0.261 | -0.442 | -0.042 | -0.234 | -0.056 | -0.001 | 0 |
| Other Total Stockholders Equity
| 1,578.358 | 1,562.247 | 1,536.8 | 1,425.115 | 1,188.81 | 1,150.583 | 493.823 | 365.298 | 292.621 | 93.812 | -63.364 | 0 |
| Total Shareholders Equity
| -30.584 | 9.342 | 76.456 | 247.618 | 394.757 | 635.928 | 119.331 | 68.12 | 130.998 | 104.078 | 30.755 | -2.679 |
| Total Equity
| -30.584 | 9.342 | 76.456 | 247.618 | 394.757 | 635.928 | 119.331 | 68.12 | 130.998 | 104.078 | 30.755 | -2.679 |
| Total Liabilities & Shareholders Equity
| 241.703 | 351.83 | 525.55 | 644.139 | 771.201 | 996.54 | 364.247 | 300.216 | 142.94 | 110.995 | 34.665 | 2.244 |